CLINICALLY RECOGNIZED ERROR RATE AFTER TRANSFER OF A SINGLE EMBRYO SCREENED BY NEXT-GENERATION SEQUENCING IS 0.06%

strict warning: Declaration of views_plugin_style_default::options() should be compatible with views_object::options() in /home/tcmlorne/public_html/modules/views/plugins/views_plugin_style_default.inc on line 0.

Preimplantation genetic testing for aneuploidy (PGT-A) is routinely used to improve pregnancy outcomes in in vitro fertilization (IVF). Although next-generation sequencing (NGS) is the most accurate technology for aneuploidy testing to date, it remains subject to error. No study has yet evaluated how often an abnormal cytogenetic diagnosis is made after a prior euploid result from an NGS platform.